Brandenburg Kapital - News about SphingoTec GmbH

Uniklinik RWTH Aachen is the first hospital to implement SphingoTec's innovative biomarkers


Potsdam - Januar 2021. With the aim of making intensive care diagnostics more precise, the Uniklinik RWTH Aachen has successfully translated the collaboration for research and biomarker validation with SphingoTec GmbH into clinical routine. The routine measurements of the innovative biomarkers are providing organ-specific information for monitoring critical care conditions such as sepsis and acute kidney injury and support clinical decisions to improve patient outcomes.

Brandenburg Kapital GmbH has been supporting the company since 2018.

Read the complete press release int the attached download.

For further information, please visit: www.brandenburg-kapital.de and www.sphingotec.com